OPCH Option Care Health - RESULTS: Q2, Q2 net REV rises 1.9% to $1.44B - SEC filing, Q2 ADJ diluted EPS up 9.8% to $0.45 - SEC filing, Optio
OPCH Option Care Health - RESULTS: Q2, Q2 net REV rises 1.9% to $1.44B - SEC filing, Q2 ADJ diluted EPS up 9.8% to $0.45 - SEC filing, Option Care Health - Earnings Notes:, Sees FY2026 ADJ diluted EPS $1.85-$1.92 - SEC filing, Sees FY2026 net REV $5.68B-$5.78B - SEC filing, Outlook Q3 sequential net REV growth in the low to mid single-digits, Outlook Q3 sequential ADJ EBITDA growth in the mid single-digits
OPCH Option Care Health - RESULTS: Q2, Q2 net REV rises 1.9% to $1.44B - SEC filing, Q2 ADJ diluted EPS up 9.8% to $0.45 - SEC filing, Option Care Health - Earnings Notes:, Sees FY2026 ADJ diluted EPS $1.85-$1.92 - SEC filing, Sees FY2026 net REV $5.68B-$5.78B - SEC filing, Outlook Q3 sequential net REV growth in the low to mid single-digits, Outlook Q3 sequential ADJ EBITDA growth in the mid single-digits